Yunling Li

Yunling Li

Auto-generated profile, based on publicly available information

Yunling Li

Department of Special Diagnosis, Shandong Cancer Hospital and Institute Affiliated to Shandong First Medical University, Jinan, Shandong Province, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
YLYan-Bing Liu
Yan-Bing Liu
MXMei Xia
Mei Xia
YLYun-Jie Li
Yun-Jie Li
SLSheng Li
Sheng Li
HLHao Li
Hao Li
YLYun-Ling Li
Yun-Ling Li

1 September 2015 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
YZYuehuan Zhao
Yuehuan Zhao
YJYanlei Ji
Yanlei Ji
ZHZhen Han
Zhen Han
LSLimei Shao
Limei Shao
YLYunling Li
Yunling Li
Long ZhaoLong Zhao
Long Zhao
Acute pancreatitis is a rare complication in postoperative colorectal cancer patients after FOLFOX6 (oxaliplatin + calcium folinate +5-FU [5-fluorouracil]) chemotherapy. In this paper, a total of 62 patients with gastrointestinal cancer were observed after the burst of acute pancreatitis. Surgery of the 62 cases of colorectal cancer patients was completed successfully. But when they underwent FOLFOX6 chemotherapy, five patients got acute pancreatitis (8.06%), four (6.45%) had mild acute pancreatitis, and one (1.61%) had severe acute pancreatitis, of which two were males (3.23%) and three females (4.84%). No patients (0.00%) had acute pancreatitis on the 1st day after chemotherapy; one patient (1.61%) got it in the first 2 and 3 days after chemotherapy; and three others (4.83%) got it in the first 4 days after chemotherapy. In the 62 patients with malignant tumors, the body mass index (BMI) was less than 18 (underweight) in six of them, with two cases of acute pancreatitis (33.33%); the BMI was 18–25 (normal weight) in 34 cases, with one case (2.94%) of acute pancreatitis; the BMI was 25–30 (overweight) in 13 cases, with 0 cases (0.00%) of acute pancreatitis; and the BMI was ≥30 (obese) in nine patients, with two cases of acute pancreatitis (22.22%). After symptomatic treatment, four patients were cured and one died; the mortality rate was 1.61%. Most of them appeared in the first 4 days after chemotherapy; the probability of this complication is significantly higher in slim and obese patients than in normal weight patients. Postoperative colorectal cancer patients after FOLFOX6 chemotherapy have a sudden onset of acute pancreatitis occult, especially in patients with severe acute pancreatitis; the symptoms are difficult to control, there is high mortality and it is worthy of clinician’s attention.

30 December 2017 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
HZHongsheng Zou
Hongsheng Zou
YXYan Xue
Yan Xue
YOYang Ou
Yang Ou
SLSheng Li
Sheng Li
YZYuehuan Zhao
Yuehuan Zhao
YLYunling Li
Yunling Li

1 April 2019 in Medicine
Verified
Journal Article
Open access
YXYan Xue
Yan Xue
HZHongsheng Zou
Hongsheng Zou
YOYang Ou
Yang Ou
SLSheng Li
Sheng Li
YZYuehuan Zhao
Yuehuan Zhao
YLYunling Li
Yunling Li
To evaluate the diagnostic performance of percentage of hard component (PHC) versus strain ratio (SR) in focal breast lesion diagnosis. Ultrasonography and elastography images of 245 malignant and 255 benign breast lesions were obtained and analyzed according to the Breast Imaging-Reporting and Data System of the American College of Radiology. PHC and SR were measured for each lesion and receiver operating characteristic (ROC) curve analysis was performed to evaluate and compare the diagnostic performance of conventional ultrasound (CU) only, PHC with CU, and SR with CU. Mean PHC differed significantly between malignant (90.46 ± 13.29) and benign (62.03 ± 25.61) lesions. Mean SR differed significantly between malignant (4.61 ± 1.75) and benign (2.34 ± 1.80) lesions. ROC curve threshold values were 82.45 for PHC and 2.69 for SR. The area under the curve values for CU, SR with CU, and PHC with CU were 0.956, 0.960, and 0.956, respectively, with no significant differences among them (P < .05). PHC was comparable to SR for differentiating malignant from benign breast masses and may be an auxiliary tool for breast lesion stiffness evaluation. ROC data for CU, SR with CU, and PHC with CU were statistically similar.